Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,892,150
+$1,092,371 QoQ
Shares Held
3,245
+6.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#1,909
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $17,780,353 across 10 Drug Manufacturers - General names. LLY ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,947 | $4,050,059 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,245 | $3,892,150 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,037 | $2,703,254 | |
| 4 | ABBV |
AbbVie Inc.
|
9,282 | $2,335,722 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,874 | $1,752,841 | |
| 6 | AMGN |
Amgen Inc
|
3,488 | $1,263,074 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,974 | $747,561 | |
| 8 | PFE |
Pfizer Inc
|
21,776 | $524,366 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,892,150 | 3,245 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,799,779 | 3,044 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $4,392,217 | 4,087 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,493,484 | 3,268 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,053,282 | 2,634 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,058,993 | 2,493 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,863,608 | 2,414 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,166,123 | 2,445 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,118,589 | 2,340 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,773,748 | 2,280 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,450,304 | 2,488 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,348,733 | 2,511 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $264,035 | 563 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $368,833 | 1,074 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,019,596 | 2,787 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $881,128 | 2,725 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $921,785 | 2,843 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $754,012 | 2,633 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $616,246 | 2,231 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $502,302 | 2,174 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $473,040 | 2,061 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $321,517 | 1,721 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $113,629 | 673 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||